Core Viewpoint - The announcement details the completion of a share reduction plan by major shareholders of Beijing Tianzhihang Medical Technology Co., Ltd, specifically the Advanced Manufacturing Industry Investment Fund and the Beijing-Tianjin-Hebei Industry Collaborative Development Investment Fund, both of which are acting in concert. Group 1: Major Shareholder Holdings - Before the reduction plan, the Advanced Manufacturing Fund held 19,308,206 shares, accounting for 4.23% of the total share capital of Tianzhihang. The Beijing-Tianjin-Hebei Fund held 19,310,707 shares, also representing 4.23% of the total share capital. Both funds hold unrestricted tradable shares and are considered concerted actors [1][2]. Group 2: Implementation Results of the Reduction Plan - As of February 2, 2026, the reduction plan was completed. The Advanced Manufacturing Fund reduced its holdings by 2,279,960 shares through centralized bidding, representing 0.50% of the total share capital, and by 4,559,920 shares through block trading, representing 1.00% of the total share capital. The Beijing-Tianjin-Hebei Fund similarly reduced its holdings by 2,279,960 shares through centralized bidding and by 4,559,920 shares through block trading, each also representing 0.50% and 1.00% of the total share capital, respectively [2][4]. Group 3: Compliance and Confirmation - The reduction plan was executed in accordance with relevant laws and regulations, and the actual reduction was consistent with the previously disclosed plan. The plan was fully implemented within the designated time frame, and there were no violations of the reduction plan or other commitments [4][5].

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 ● 重要内容提示： 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603998 证券简称：方盛制药 公告编号：2026-008 湖南方盛制药股份有限公司 关于公司参与投资设立的并购基金对外出售投资 项目部分股份的进展公告 1、同系方盛已于近期召开合伙人会议，同意将其存续期延长一年至2027年1月31日，同意同系泰兴、同 系未来将其分别持有的同系方盛未实缴出资额31.70万元（实缴出资28.30万元）、285.30万元退伙（实 缴出资254.70万元），同系方盛认缴出资额由47,065.83万元减少为46,748.83万元； 2、根据此前约定，同系方盛在收回全部回购款项后不再持有湖南珂信股权；此外，目前武汉珂信6%的 股权已过户至同系方盛名下； 3、根据湖南珂信提供的长沙珂信相关数据，长沙珂信2025年度扣除非经常性损益后的净利润已达到向 盈康生命作出的首年业绩承诺目标，预计将触发盈康生命收购湖南珂信持有的长沙珂信29%股权的条 件，但具体交易尚需要各方履行相关审批程 ...

Core Viewpoint - The company, Xindao Technology, focuses on the research and sales of power semiconductors, with a significant emphasis on product innovation and market expansion in various sectors, including consumer electronics, automotive, and renewable energy [7][14][15]. Company Overview - Xindao Technology operates under a Fabless model, concentrating on the design of power semiconductor products while outsourcing manufacturing and testing processes [8][10]. - The company's main products include power devices such as TVS, MOSFETs, and IGBTs, as well as power ICs for power management applications [14][15]. Industry Situation - The global semiconductor market is projected to grow significantly, with a forecasted revenue of $753 billion in November 2025, reflecting a year-on-year increase of 29.8% [13]. - China's semiconductor sales are expected to exceed $180 billion in 2025, capturing approximately 27.8% of the global market share [13]. - The industry is experiencing a shift towards domestic production due to geopolitical tensions, creating substantial opportunities for local manufacturers [17]. Financial Performance - In the reporting period, the company achieved a revenue of 393.61 million yuan, an increase of 11.52% year-on-year, while net profit attributable to shareholders decreased by 4.91% to 106.15 million yuan [21]. - The company plans to distribute a cash dividend of 4.30 yuan per 10 shares, amounting to a total of 50.57 million yuan, which represents 47.64% of the net profit for the year [5]. Future Development Trends - The semiconductor market is expected to rebound sharply in 2024, driven by emerging applications such as AI, electric vehicles, and data centers, with a compound annual growth rate of 6.8% projected until 2030 [16]. - The demand for power devices is anticipated to grow due to the dual carbon goals, with a focus on high-voltage and low-power applications in sectors like electric vehicles and renewable energy [20].

Group 1 - The company announced the resignation of Vice President Cai Min due to personal reasons, effective from February 2, 2026 [1] - Cai Min will not hold any position in the company or its subsidiaries after his resignation, which was originally set from November 6, 2025, to July 27, 2028 [1] - The board expressed gratitude for Cai Min's contributions during his tenure, stating that his departure will not affect the company's daily operations [1] Group 2 - The resignation report of Cai Min is available as a reference document [1]

登录新浪财经APP 搜索【信披】查看更多考评等级 公告送出日期：2026年2月3日 1公告基本信息 ■ 注：鹏华上证科创板芯片设计主题交易型开放式指数证券投资基金的场内简称为"芯设计KC"，扩位简 称为"科创芯片设计ETF鹏华"。 2 日常申购、赎回业务的办理时间 鹏华上证科创板芯片设计主题交易型开放式指数证券投资基金（以下简称"本基金"）自2026年2月6日起 （含当日）开始办理申购、赎回业务。 3 申购和赎回业务 3.1 申购与赎回的数量限制 1、投资人申购、赎回的基金份额需为最小申购、赎回单位的整数倍。自2026年2月6日起，本基金的最 小申购、赎回单位调整为300万份。最小申购、赎回单位由基金管理人综合考虑对投资组合跟踪偏离度 和跟踪误差的影响以及市场需求等因素确定和调整。 2、基金管理人可设定申购份额上限和赎回份额上限，以对当日的申购总规模或赎回总规模进行控制， 并在申购赎回清单中公告。 3、当接受申购申请对存量基金份额持有人利益构成潜在重大不利影响时，基金管理人应当采取设定单 一投资者申购份额上限或基金单日净申购比例上限、拒绝大额申购、暂停基金申购等措施，切实保护存 量基金份额持有人的合法权益。基 ...

Core Viewpoint - Jiangsu Xiehe Electronics Co., Ltd. is collaborating with private equity funds to establish a venture capital fund, aiming to enhance its understanding of high-tech industries and expand its industrial resources while ensuring stable development of its main business [2][37]. Group 1: Investment Details - The company is participating as a limited partner with its own funds of 5 million RMB, accounting for approximately 7.30% of the total subscribed capital of the partnership, which amounts to 68.5 million RMB [2][5]. - The transaction has been approved by the company's general manager's office and does not require further approval from the board of directors or shareholders [3][5]. Group 2: Partnership Structure - The partnership agreement involves several other partners, including Changzhou Lizhong Investment Management Co., Ltd. and others, to jointly invest in the establishment of the venture capital fund [5][6]. - The fund's purpose is to achieve stable asset appreciation while controlling investment risks, focusing on venture capital investments in unlisted companies [8]. Group 3: Fund Management and Operations - The fund will have a duration of five years, with a three-year investment period and a two-year exit period, and can be extended under certain conditions [8]. - The fund's investment strategy will primarily target high-tech sectors, including smart detection services, high-end equipment, robotics, and artificial intelligence, mainly in the Yangtze River Delta region [30]. Group 4: Financial Impact - The investment is made using the company's own funds, ensuring that it does not affect the company's operational capital needs or normal business activities, and is aligned with the interests of all shareholders [37].

Core Viewpoint - The announcement details a share reduction plan by significant shareholders of Haishike Pharmaceutical Group Co., Ltd., indicating a total potential reduction of up to 10,000,000 shares, which is approximately 0.89% of the company's total share capital [2][3]. Group 1: Shareholder Information - Shareholder Hao Congmei holds 3,518,000 shares, representing 0.31% of the total share capital, while shareholder Yang Fei holds 42,442,286 shares, representing 3.79% of the total share capital [2]. - The reduction plan involves Hao Congmei planning to reduce up to 2,000,000 shares (0.18% of total share capital) and Yang Fei planning to reduce up to 8,000,000 shares (0.71% of total share capital) [3]. Group 2: Reduction Plan Details - The reduction will occur within three months following a 15 trading day period after the announcement, using block trades or centralized bidding [2][3]. - The reason for the reduction is stated as personal funding needs [3]. - The shares to be reduced were originally acquired through block trades in 2015 [3]. Group 3: Compliance and Commitments - The shareholders have committed to avoiding any competition with the company's main business and ensuring that any related transactions are conducted fairly and transparently [5]. - The shareholders confirm that there are no circumstances that would prevent them from reducing their shares as per the regulations [5].

Core Viewpoint - The announcement details the establishment of a special account for raised funds and the signing of a tripartite supervision agreement to ensure proper management and protection of investors' rights [1][2]. Fundraising Basic Information - The company has received approval from the China Securities Regulatory Commission for its initial public offering, issuing 19,600,000 shares at a price of RMB 24.75 per share, raising a total of RMB 48,510.00 million. After deducting issuance costs of RMB 8,805.29 million, the net amount raised is RMB 39,704.71 million [1]. Fund Management and Supervision Agreement - The company has opened a special account for the raised funds and signed a tripartite supervision agreement with China Industrial and Commercial Bank and Guotai Junan Securities to regulate fund management and protect investors' rights [2][3]. - The agreement stipulates that the special account is exclusively for the storage and use of funds related to specific projects, such as the "Technology Center Construction Project" and "Supplementing Working Capital Project" [3][7]. Responsibilities and Oversight - The supervising institution (Guotai Junan Securities) is responsible for monitoring the use of the raised funds, conducting semi-annual inspections, and ensuring compliance with relevant laws and regulations [4][8]. - The supervising institution has the authority to change designated representatives and must be notified of any significant withdrawals from the special account [5][9]. Account Management - The bank will provide monthly account statements to the company and the supervising institution, ensuring the accuracy and completeness of the information [5][9]. - If the company withdraws more than RMB 50 million or 20% of the net raised funds within a twelve-month period, the bank must promptly notify the supervising institution [5][9]. Agreement Validity - The tripartite agreement becomes effective upon signing and remains valid until all funds are fully utilized and the account is closed [10][11].

Core Viewpoint - Zhejiang Bangjie Holdings Group Co., Ltd. and its subsidiary, Yangzhou Bangjie New Energy Technology Co., Ltd., are undergoing a pre-restructuring process due to financial difficulties, initiated by a creditor's application for bankruptcy restructuring [2][6]. Group 1: Bankruptcy Restructuring Process - On September 4, 2025, the company disclosed that Yangzhou Bangjie received a notice from the court regarding a creditor's application for pre-restructuring due to its inability to repay debts [2]. - The court accepted the pre-restructuring application on September 16, 2025, and appointed a management team for the restructuring process on November 18, 2025 [2][3]. - The court officially accepted the restructuring application on January 30, 2026, but has not yet appointed a manager for the process [3][6]. Group 2: Financial Obligations and Risks - Yangzhou Bangjie has a financial liability exposure of approximately 630 million yuan, with all financial liabilities guaranteed by the company, posing a risk of fulfilling these obligations [10]. - The company has invested 505 million yuan directly and indirectly in Yangzhou Bangjie, which may lead to risks of unrecoverable investments due to the restructuring [10]. - The company is also a significant creditor, having provided around 650 million yuan in financial support to Yangzhou Bangjie, which may result in risks of uncollectible receivables [11]. Group 3: Impact on Business Operations - Yangzhou Bangjie is a core subsidiary and an important operational platform for the company's photovoltaic business; successful restructuring could improve the company's financial structure [10]. - The ongoing restructuring process may negatively impact the company's seamless clothing business, which has historically generated significant revenue [14]. - The company is closely monitoring the restructuring developments and will disclose relevant information as required [14].

Core Viewpoint - The company plans to utilize idle self-owned funds for cash management to enhance fund efficiency and increase returns for the company and its shareholders [3][9]. Group 1: Cash Management Details - The company intends to invest up to RMB 30 million (maximum daily balance, including this amount) in cash management products [3][6]. - The investment period for the cash management will not exceed 12 months from the date of board approval [5][6]. - The source of funds for this cash management is the company's idle self-owned funds [4]. Group 2: Approval Process - The company held meetings on December 29, 2025, where the board's audit committee and independent directors approved the cash management proposal, which does not require shareholder approval [2][6]. - The sponsor, ShenGang Securities Co., Ltd., provided a non-objection opinion on this matter [2][6]. Group 3: Investment Purpose and Strategy - The purpose of the investment is to improve the efficiency of idle funds without affecting daily operational funds and ensuring fund safety [3][9]. - The company will select financial products that are high in safety, good in liquidity, and low in risk for cash management [2][7]. Group 4: Impact on Company - The cash management will not affect the company's main business development and is expected to enhance the efficiency of fund usage and cash asset returns, benefiting all shareholders [9].